Targeting iron to contrast cancer progression

Area of Science:

• Oncology
• Cancer Biology
• Drug Discovery

Background:

• Iron metabolism plays a critical role in cancer cell growth, invasion, metastasis, and recurrence.
• Cancer cells and their tumor microenvironment exhibit a complex iron-trafficking program involving malignant cells, cancer stem cells, immune cells, and stromal components.

Purpose of the Study:

• To explore the role of iron metabolism in cancer progression.
• To investigate iron-binding strategies as a therapeutic approach for cancer treatment.
• To highlight the potential of iron-targeting drugs in overcoming cancer recurrence and therapy resistance.

Main Methods:

• Review of ongoing research in cancer biology and iron metabolism.
• Analysis of iron-binding strategies in anticancer drug discovery, including clinical trials.
• Examination of polypharmacological mechanisms of action and iron-associated biomarkers.

Main Results:

• Iron dysregulation is a key driver of multiple facets of cancer progression.
• Iron-binding drug candidates are under development and in clinical trials.
• Emerging biomarkers and companion diagnostics are being identified for iron-associated therapies.

Conclusions:

• Targeting iron metabolism represents a promising therapeutic strategy for a broad spectrum of cancers.
• Iron-binding drugs, as monotherapy or in combination, have the potential to address significant clinical challenges like cancer recurrence and drug resistance.